Insider · CIK 0001208907
Thomas G Wiggans
Files at ANNX (Annexon, Inc.), JSPR (Jasper Therapeutics, Inc.). First filing Sep 24, 2025, latest Sep 24, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JSPR: Jasper Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 66Notable | Jasper Therapeutics, Inc. | $100k 41,000 shares | - | +9% from low-90% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | POpen-market purchase Voting Common Stockindirect: By Wiggans Living Trust | +41,000 | $2.43 | $100k | 41,000 | Sep 24, 2025 |
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | POpen-market purchase Common Stock Warrant (right to buy)derivativeindirect: By Wiggans Living Trust | +41,000 | - | - | 41,000 | Sep 24, 2025 |
| Jul 3, 2025 | JSPR Jasper Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,500 | $0.00 | $0 | 7,500 | Jul 3, 2025 |
| Jun 5, 2025 | ANNX Annexon, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Jun 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.